Related Experiment Video
Updated: Aug 8, 2026

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
Published on: December 31, 2014
The organization and expression of the mdm2 gene
R M de Oca Luna1, A D Tabor, H Eberspaecher
1Department of Molecular Genetics, University of Texas, M. D. Anderson Cancer Center, Houston, Texas, 77030, USA.
Abstract:
The mdm2 gene encodes a zinc finger protein that negatively regulates p53 function by binding and masking the p53 transcriptional activation domain. Two different promoters control expression of mdm2, one of which is also transactivated by p53. We cloned and characterized the mdm2 gene from a murine 129 library. It contained at least 12 exons and spanned approximately 25 kb of DNA. Sequencing of the mdm2 gene revealed three nucleotide differences that resulted in amino acid substitutions in the previously published mdm2 sequence. Sequencing of normal BalbC/J DNA and the original cosmid clone isolated from the 3T3DM cell line revealed that they are identical, suggesting that the published sequence is in error at these three positions. In addition, we analyzed the expression pattern of mdm2 and found ubiquitous low-level expression throughout embryo development and in adult tissues. Analysis of mRNA from numerous tissues for several mdm2 spliced variants that had been identified in the transformed 3T3DM cell line revealed that these variants could not be detected in the developing embryo or in adult tissues.
Insights
The mdm2 gene, crucial for regulating p53, was cloned and sequenced from mice. Researchers identified errors in prior mdm2 gene sequences and found its variants are not present in developing embryos or adult tissues.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- The mdm2 gene encodes a protein that inhibits p53 tumor suppressor activity.
- mdm2 expression is regulated by two promoters, one of which is activated by p53.
- Understanding mdm2's structure and expression is vital for cancer research.
Purpose of the Study:
- To clone and characterize the murine mdm2 gene.
- To identify and correct potential errors in the existing mdm2 gene sequence.
- To investigate the expression patterns of mdm2 and its splice variants during development and in adult tissues.
Main Methods:
- Cloning of the mdm2 gene from a murine 129 library.
- DNA sequencing to analyze gene structure and identify nucleotide differences.
- mRNA analysis to detect mdm2 expression and splice variants in various tissues.
Main Results:
- The murine mdm2 gene spans approximately 25 kb and contains at least 12 exons.
- Three nucleotide differences were found compared to the published mdm2 sequence, indicating potential errors in prior studies.
- Ubiquitous low-level expression of mdm2 was observed throughout embryonic development and in adult tissues.
- Identified mdm2 splice variants were not detected in embryonic or adult tissues.
Conclusions:
- The study provides a corrected sequence for the murine mdm2 gene.
- The findings suggest that specific mdm2 splice variants found in transformed cells may not play a role in normal development or adult tissues.
- Further research is needed to elucidate the functional significance of mdm2 and its variants in normal physiology and disease.
More Related Videos
13:15Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
Published on: February 25, 2016
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
Related Concept Videos
Epigenetic Regulation
Master Transcription Regulators
Positive Regulator Molecules
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...